Please assess the completion status of the following clinical trial:

Trial Title: Post Market Evaluation of Aer-O-Scope Visualization

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: SCREENING
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Subject is indicated for screening, diagnostic (minor complaints such as rectal bleeding or minor abdominal pain) or surveillance colonoscopy~2. Subject willing to undergo tandem colonoscopies with Aer-O-Scope Colonoscope and a conventional colonoscope (including a single colon preparation bowel cleansing)~3. Subject between the ages of 45 and 75 (patients between the ages of 45 and 50 must have a family history of a first degree relative with onset of colon cancer before the age of 60).~4. Subject is able to understand and willing to sign informed consent form~Exclusion Criteria:~1. Personal history of colorectal neoplasia including familial adenomatous polyposis or hereditary nonpolyposis, colon cancer (HNPCC).~2. Diagnosis of active (flaring) inflammatory bowel disease (active ulcerative colitis or Crohn's colitis), bowel obstruction, or acute diverticulitis, or known severe diverticulosis, fecal incontinence or any known large-bowel disease that would require a predetermined therapeutic colonoscopy (non-screening, non-diagnostic or non-surveillance cases)~3. Severe gastrointestinal tract-related symptoms, or complaints, suggesting performance of a pre-determined therapeutic colonoscopy (non-screening, non-diagnostic or non-surveillance cases)~4. History of colonic resection~5. Clinically significant cardiovascular or pulmonary disease.~6. Cancer or other life threatening disease or significant chronic condition that puts the subject at risk.~7. Blood-clotting disorders and/or current anticoagulant therapy (Subjects taking up to 100mg aspirin for prophylactic treatment are acceptable for this study)~8. Pregnancy~9. Previous radiation therapy to the abdomen~10. Morbid Obesity (BMI \> 40 kg/m2)~11. Drug abuse or alcoholism~12. Subject is bed-ridden and/or unable to adequately communicate~13. Subject is under custodial care~14. Subject has a history of psychiatric disorders which would prevent compliance with study instructions~15. Participation in a clinical study within the previous 30 days

- Gender: ALL
- Minimum Age: 45 Years
- Maximum Age: 75 Years
- Healthy Volunteers: t

Study Arms:
- Aer-O-Scope First (Type: ACTIVE_COMPARATOR): Patients in this arm will undergo colonoscopy using the Aer-O-Scope followed by colonoscopy using a conventional colonoscope
- Conventional Colonoscope First (Type: ACTIVE_COMPARATOR): Patients in this arm will undergo colonoscopy using a conventional colonoscope followed by colonoscopy using the Aer-O-Scope

Based on this trial design, predict the completion outcome and termination type (if applicable).